Home / Compare / MindScape Retreat vs Texas ibogaine trials (IMPACT consortium)

MindScape Retreat vs Texas ibogaine trials (IMPACT consortium)

MindScape Retreat and Texas ibogaine trials (IMPACT consortium) side by side: setting, medical team, screening, what is given, length of stay, aftercare, published price and public record. See also the questions to ask.

	MindScape Retreat	Texas ibogaine trials (IMPACT consortium) Status unconfirmedClinical trial
Category	Residential clinic with physician at every session	State-funded clinical trial program, not enrolling as of October 2026
Location	Cozumel, Mexico	Houston and Galveston, United States
Setting	Residential retreat in three properties on Cozumel; the program describes itself as a clinic.	Academic hospitals, under an FDA-supervised protocol, once the trial exists.
Medical team	Dr. Arellano MD, clinical director; a physician on site 24/7 and a physician plus nurse at every session; continuous chest-strap cardiac monitoring.	University physicians and researchers.
Screening before treatment	EKG before admission and baseline labs. Methadone and Suboxone patients get a supervised taper on site "as part of the protocol"; short-acting opioids get a brief stabilisation.	Trial eligibility criteria, not yet published.
What is given	Main form not stated; a total alkaloid (TA) extract is used for the "TA Booster Protocol".	To be set by the FDA-approved protocol.
Who it is for	Opioids, fentanyl, methadone and Suboxone, alcohol, cocaine, methamphetamine, kratom, depression, anxiety, PTSD, CPTSD and TBI, SSRI discontinuation, Parkinson's; also 5-MeO-DMT programs.	Addiction, TBI and other behavioural conditions (the IMPACT consortium: Ibogaine Medicine for PTSD, Addiction and Cognitive Trauma).
Protocol and length of stay	Core 7 days; opioid and SSRI protocols 10 to 14 days; alcohol 10 to 12; Parkinson's 14 to 18; 5-MeO-DMT 3 to 5.	A two-year multicentre trial is planned. As of October 2026 no federally authorised ibogaine trial exists in the United States (ARPA-H).
After the treatment	90-day integration plan, coaching calls, alumni community and app; a one-month microdose supply for programs of 10 days or more.	Per protocol.
Published price	From $7,500 for the 5-day program; $13,500 for the full protocol, all-inclusive (site). recovery.com: $7,500 to $19,500.	No fee expected for trial participants.
Licences and accreditations stated	"Board-certified", "licensed" physicians and "HIPAA-aligned" claimed; no licence number; a credentials packet is offered on request.	Texas SB 2308, signed June 2025, appropriated $50 million; HHSC selected UTHealth Houston and UTMB on December 12, 2025.
Founded / history	"Since 2019" (site).	The statute bars disbursement until non-state matching funds arrive. In March 2026 HHSC said no drug-company proposal met the match requirements; state leaders said Texas would fully fund the program. As of October 8, 2026 no executed contract or disbursement had been confirmed.
Rating (as shown on the cited page)	4.5 from 75 reviews (recovery.com, 2026-10-20)	Not shown on the pages we checked
Public record	None found.	None found.
Status	Operating. Site copyright 2026, reviewed May 2026, phone listed. The site shows its own figure of 4.9 from 522 reviews. It also publishes an ibogaine policy tracker.	Status unconfirmed. Not enrolling. Anyone searching for ibogaine in Texas today cannot get it through this program yet.

From each program's website and the sources on its profile, checked 2026-10-20.

Compare other programs